12/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

12/2023

Dec 23, 2023, 15:58 | Blog
Vivek Subbiah: Here's to four decades of impactful research!
Vivek Subbiah shared on X/Twitter: "Milestone alert! Celebrating Journal of Clinical Oncology's 40th anniversary. Huge…
Dec 23, 2023, 15:43 | Blog
Aaron Goodman: How I do AML induction 1 tweet
Aaron Goodman shared a post on X/Twitter: “How I do AML induction 1 tweet (it's not…
Dec 23, 2023, 08:10 | Blog
Vivek Ramaswamy: I stepped down from my job as a biotech CEO
Vivek Ramaswamy, the founder of Roivant Sciences and American presidential candidate, shared on X: "I…
Dec 23, 2023, 04:00 | Insight
Vivek Subbiah: Such a delight to share our non-human primate publication as a pre-cursor to our First-in-human phase 1 trial
Vivek Subbiah shared on X/Twitter: ''Such a delight to share our non-human primate publication on First-in-cynomolgus…
Dec 23, 2023, 03:55 | Blog
Shilpa Gupta: Our work on plat-ineligibility in Metastatic Urothelial Carcinoma and survival outcomes out in the Journal of the JNCI
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X/Twitter: "Our…
Dec 23, 2023, 03:51 | Blog
Iván González: Interesting review that addresses the importance of the RAS/RAF/MAPK pathway in solid cancers
Iván González, Medical Oncologist at the Ángeles Puebla Hospital, shared a post on X/Twitter: "A…
Dec 23, 2023, 03:46 | Blog
Barts Health NHS Trust: Tom Powles features in Nature’s 10
Barts Health NHS Trust shared on LinkedIn: “A Barts Health doctor whose research has helped…
Dec 23, 2023, 03:36 | Blog
Vincent Rajkumar: Updated treatment approach to newly diagnosed myeloma based on new ASH 23 data
Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently posted on X/Twitter: “Updated treatment approach to…
Dec 23, 2023, 03:33 | Blog
Aaron Goodman: How I Treat in a Tweet - Follicular Lymphoma
Aaron Goodman shared a post on X/Twitter: “How I Treat in a Tweet - Follicular Lymphoma.…
Dec 23, 2023, 03:29 | Blog
David Steensma: The NIH modular R01's direct cost cap of $250K is unchanged since 1998
David Steensma, Chief Medical Officer at Ajax Therapeutics, recently posted on X/Twitter: "The NIH modular…
All: 654 Posts: 141 - 150